Redemption of all remaining Obsidian convertible notes
Filed with ASX ·
6ix is reading this filing.
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Firm commitments to raise A$4.3m and announcement of SPP
- Trading Halt
- Appendix 4C & Quarterly Update
- FDA Type C Feedback, HEALEY trial potentially registrational
- Neurizon Announces Partial Redemption of Convertible Notes
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics